Correlations between serum sirtuin levels and cardiovascular risk factors in women with polycystic ovary syndrome

• Published in: Advances in medical sciences 2022-03, Vol.67 (1), p.123-128
• Main Authors: Charążka, Beata, Siejka, Agnieszka
• Format: Article
• Language: English
• Subjects: Body Mass Index; Cardiovascular Diseases; Cardiovascular risk; Diabetes Mellitus, Type 2 - complications; Female; Heart Disease Risk Factors; Humans; Insulin Resistance - physiology; Polycystic ovary syndrome; Polycystic Ovary Syndrome - complications; Risk Factors; Sirtuins
• ISSN: 1896-1126; 1898-4002
• DOI: 10.1016/j.advms.2022.01.004

Polycystic ovary syndrome (PCOS) is associated with an increased risk of cardiovascular disease (CVD) and metabolic complications often related to obesity, such as insulin resistance and type 2 diabetes mellitus (T2DM). Sirtuins (SIRTs) are nicotinamide adenine dinucleotide NAD+-dependent histone deacetylases, which modulate protein post-translational modifications (PTMs), gene transcription, increase repairing activities of DNA, and regulate metabolic processes. The aim of our study was to measure the serum levels of SIRTs 1, 2, 3, 6 and 7, and evaluate correlations between SIRTs levels and cardiovascular risk factors in women with PCOS. The study included 54 women with PCOS and 33 healthy volunteers. Concentrations of SIRTs were measured by ELISA technique. Mean serum levels of SIRTs did not differ significantly between PCOS and controls. SIRTs 1, 2, and 6 positively correlated with HDL, while SIRTs 2 and 6 negatively correlated with LDL cholesterol. Negative correlation between SIRT 3 and HOMA-IR and negative correlations of SIRT 1 and 2 with insulin 120′ in oral glucose tolerance test (OGTT) were demonstrated. A positive correlation between BMI and SIRT 7 concentration, and a positive correlation between body weight and SIRT 7 concentration were verified in the study group. The observed correlations between concentrations of SIRTs and metabolic parameters may indicate the involvement of these factors in the development of cardiometabolic complications. The results may indicate the involvement of SIRTs in the development of cardiometabolic complications. However, additional studies are required to validate this observation.